We are live on ! Find out more
BSX icon

Boston Scientific

1,643 hedge funds and large institutions have $135B invested in Boston Scientific in 2025 Q1 according to their latest regulatory filings, with 230 funds opening new positions, 667 increasing their positions, 553 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

215% more first-time investments, than exits

New positions opened: 230 | Existing positions closed: 73

31% more call options, than puts

Call options by funds: $1.07B | Put options by funds: $819M

31% more funds holding in top 10

Funds holding in top 10: 3951 (+12)

21% more repeat investments, than reductions

Existing positions increased: 667 | Existing positions reduced: 553

12% more capital invested

Capital invested by funds: $120B → $135B (+$14.8B)

9% more funds holding

Funds holding: 1,5131,643 (+130)

0.19% less ownership

Funds ownership: 90.98%90.79% (-0.19%)

Holders
1,643
Holders Change
+130
Holders Change %
+8.59%
% of All Funds
22.03%
Holding in Top 10
51
Holding in Top 10 Change
+12
Holding in Top 10 Change %
+30.77%
% of All Funds
0.68%
New
230
Increased
667
Reduced
553
Closed
73
Calls
$1.07B
Puts
$819M
Net Calls
+$256M
Net Calls Change
+$371M
Name Holding Trade Value Shares
Change
Change in
Stake
Carson Wealth (CWM LLC)
576
Carson Wealth (CWM LLC)
Nebraska
$3.78M +$286K +2,844 +8%
FTWA
577
Fifth Third Wealth Advisors
Ohio
$3.76M +$560K +5,566 +18%
LRWA
578
Long Run Wealth Advisors
New York
$3.75M -$255K -2,536 -6%
RF
579
Robbins Farley
New Hampshire
$3.74M +$3.73M +37,080 New
VCM
580
Voleon Capital Management
California
$3.67M -$1.98M -19,632 -35%
SB
581
SIG Brokerage
New York
$3.67M +$3.66M +36,336 New
GIM
582
Goelzer Investment Management
Indiana
$3.65M +$82.2K +816 +2%
AAM
583
Advisors Asset Management
Colorado
$3.61M +$188K +1,863 +5%
EWA
584
EP Wealth Advisors
California
$3.59M +$1.63M +16,149 +83%
Kovitz Investment Group Partners
585
Kovitz Investment Group Partners
Illinois
$3.54M +$1.49M +14,759 +73%
RWM
586
Ritholtz Wealth Management
New York
$3.54M +$243K +2,413 +7%
GAM
587
Gotham Asset Management
New York
$3.53M +$2.37M +23,542 +206%
TF
588
Trek Financial
Arizona
$3.48M +$3.16M +31,339 +990%
CIG
589
CHB Investment Group
Pennsylvania
$3.46M -$13.5K -134 -0.4%
MAS
590
Meeder Advisory Services
Ohio
$3.45M +$292K +2,895 +9%
USAA
591
United Services Automobile Association
Texas
$3.43M +$92K +914 +3%
BCI
592
Brinker Capital Investments
Pennsylvania
$3.37M +$282K +2,805 +9%
OPS
593
Orion Portfolio Solutions
Nebraska
$3.37M +$282K +2,805 +9%
BP
594
Ballentine Partners
Massachusetts
$3.36M +$164K +1,625 +5%
PAM
595
Pinpoint Asset Management
Hong Kong
$3.35M -$2.58M -25,627 -44%
Empower Advisory Group
596
Empower Advisory Group
Colorado
$3.31M +$2.22M +22,005 +204%
PIM
597
Penobscot Investment Management
Massachusetts
$3.27M +$410K +4,075 +14%
S
598
SignatureFD
Georgia
$3.27M +$321K +3,184 +11%
BS
599
Banco Santander
Spain
$3.23M +$1.55M +15,356 +92%
EAM
600
Eventide Asset Management
Massachusetts
$3.23M +$492K +4,886 +18%

BSX Hedge Fund Activity: Q1 2025 in Review

1,643 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2025, worth a combined $135B — up 12% from $120B a quarter earlier.

Buyers outnumbered sellers: 230 funds opened new BSX positions and 73 closed out — a net gain of 157 holders — while 667 added to existing stakes and 553 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $532M. The largest seller was Franklin Resources, cutting an estimated $915M.

  • 1,643 institutional investors held Boston Scientific (BSX) as of Q1 2025, up from 1,513 in Q4 2024.
  • Funds reported $135B of Boston Scientific stock for Q1 2025, up 12% quarter-over-quarter.
  • 230 funds opened new Boston Scientific positions in Q1 2025 and 73 closed out, a net change of +157 holders.
  • The largest Boston Scientific buyer in Q1 2025 was JP Morgan Chase, an estimated $532M added.
  • The largest Boston Scientific seller in Q1 2025 was Franklin Resources, an estimated $915M sold.

Based on aggregated 13F filings for Q1 2025.